Halozyme Therapeutics is appointing David Ramsay Interim Chief Financial Officer (CFO), effective March 23, 2026. The active executive search for a permanent CFO will continue; Halozyme says that search is “well underway and progressing.” Ramsay has agreed to remain on board until a permanent CFO is named. Chief Financial Officer, Again The appointment marks the third time Ramsay will oversee Halozyme’s financial operations. He served two previous tenures as Halozyme’s CFO, from 2003 to...